Felix Lai

Felix Lai has worked in the pharmaceutical industry since 2003. Felix began their career at Impax Laboratories, where they held roles such as Manager, Product Development; Group Leader, Product Development; Associate Director, Product Development; Director, Formulation and Process Development; and Sr. Director, Product Development. In 2018, they moved to Protagonist Therapeutics, where they were Director, Formulation Development and Manufacturing and Associate Director, Formulation Development. In 2021, they took a position at Aligos Therapeutics as Director, Drug Product Development. Most recently, they joined Carmot Therapeutics, Inc. in 2022 as Sr. Director, CMC Pharmaceutical Development.

Felix Lai obtained a BS in Chemical Engineering from the University of California, Berkeley between 1993 and 1997. Felix then went on to pursue a PhD in Chemical Engineering from the University of California, Davis, which they completed in 2003.